Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Breast Cancer Res Treat. 2019 May 22;177(1):29–40. doi: 10.1007/s10549-019-05279-9

Figure 1.

Figure 1.

NR4A1-regulated gene expression in breast tumors. MDA-MB-231 cells were transfected with iNR4A1 or treated with 20 μM DIM-C-pPhOH (CDIM8) for 24 h, and mRNA from each treatment was analyzed by RNAseq (A) and normalized data was analyzed by IPA (B). The NCBI database was analyzed for expression of NR4A1 mRNA and correlated with overall patient survival (C) and NR4A1 levels (y-axis) expressed in tumors assigned as Stage I-IV and metastasis (Stage X) (D).

HHS Vulnerability Disclosure